MedPath

Rhomicosin 25 LQ Oral Solution 25% w/v

Registration Number: MAL12070029HA

Approved
Approval ID

e8f0984aca1bb398

Registration Number

MAL12070029HA

Registration Date

Jul 4, 2025

Regulatory Authority
NPRA
Malaysia

Product Information

Additional product specifications and packaging information as registered with NPRA Malaysia.

Product Specifications

PRODUCT SPECIFICATIONS

Official SourceNPRA Database
Available Package Types1 type
Last UpdatedJul 4, 2025

PACKAGING INFORMATION (1)

1.00 mcg/mLAvailable
Package Size: 1.00 mcg/mL
Status: NPRA Approved

Active Ingredients

Active pharmaceutical ingredients contained in this NPRA-approved product.

Ingredients (1)

TILMICOSIN PHOSPHATEActive
Monograph: tilmicosin phosphate

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Rhomicosin 25 LQ Oral Solution 25% w/v - NPRA Drug Approval Details | MedPath - Medical Intelligence Platform